U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT06915688) titled 'A Study Comparing Doxycycline and Levofloxacin for Treating COPD Exacerbations' on March 19.
Brief Summary: This study will include patients with chronic obstructive pulmonary disease (COPD) who present with an acute exacerbation. Participants will be randomly assigned to receive either doxycycline or levofloxacin for 5 days. The aim is to compare how effective each antibiotic is in improving symptoms after 2 days of treatment.
Study Start Date: April 15
Study Type: INTERVENTIONAL
Condition:
COPD
Intervention:
DRUG: Doxycycline
Doxycycline will be given to COPD group 1
DRUG: Levofloxacin
Levofloxacin given to copd patients...